论文信息 - Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study. - 字舞流文

Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study.

S. Barni | N. Gebbia | G. Colucci | E. Maiello | V. Lorusso | F. Verderame | G. Filippelli | L. Orlando | S. Cinieri | G. Pappagallo | F. De Vita | S. Pisconti | F. Giotta | P. Fedele | F. Riccardi | L. Blasi